Morphoproteomics and biomedical analytics coincide with clinical outcomes in supporting a constant but variable role for the mTOR pathway in the biology of congenital hyperinsulinism of infancy. (2017)
Attributed to:
Title: Understanding the molecular mechanisms of hyperinsulinaemic hypoglycaemia and developing novel therapies
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13023-017-0735-9
PubMed Identifier: 29246172
Publication URI: http://europepmc.org/abstract/MED/29246172
Type: Journal Article/Review
Volume: 12
Parent Publication: Orphanet journal of rare diseases
Issue: 1
ISSN: 1750-1172